CG Oncology (CGON) Current Leases (2023 - 2026)
CG Oncology (CGON) reported Current Leases of $1.1 million for Q1 2026, up 318.04% on a YoY basis from $255000.0 in Q1 2025, and up 16.5% quarter-over-quarter from $915000.0 in Q4 2025.
CG Oncology (CGON) Current Leases (2023 - 2026) Analysis & Trends
CG Oncology has reported Current Leases for 4 years, with the latest figure at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 318.04% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 318.04% YoY), and the FY2025 full-year result was $915000.0, up 391.94% from the prior year.
- Current Leases for Q1 2026 stood at $1.1 million, up from $915000.0 in the prior quarter.
- The five-year high for Current Leases was $1.1 million in Q1 2026, with the low at $186000.0 in Q4 2024.
- Historically, Current Leases has averaged $452100.0 across 4 years, with a median of $246000.0 in 2024.
- Annual changes were most pronounced in 2024 — Current Leases retreated 14.29% — and 2025, when it soared 391.94%.
- CG Oncology's Current Leases stood at $217000.0 in 2023, then decreased by 14.29% to $186000.0 in 2024, then soared by 391.94% to $915000.0 in 2025, then rose by 16.5% to $1.1 million in 2026.
- The last three Current Leases figures came in at $1.1 million (Q1 2026), $915000.0 (Q4 2025), and $912000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | CG Oncology | 5.16 Bn | 5.16 Bn | -1.88 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 915,000.00 |
| Sep 30, 2025 | 912,000.00 |
| Jun 30, 2025 | 288,000.00 |
| Mar 31, 2025 | 255,000.00 |
| Dec 31, 2024 | 186,000.00 |
| Sep 30, 2024 | 225,000.00 |
| Jun 30, 2024 | 237,000.00 |
| Mar 31, 2024 | 220,000.00 |
| Dec 31, 2023 | 217,000.00 |